Skip to content

Macular Telangiectasia Type 2 C5232269

Published: July 22, 2026Updated: August 20, 2026

A bilateral condition affecting both eyes with leaky blood vessels in the central retina. Typically develops in middle-aged adults and slowly affects central vision.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
H53.9
ICD-11
9A00.0
Body system
ophthalmologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(ophthalmologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Slowly progressive central visual loss

(ophthalmologic)

Metamorphopsia

(ophthalmologic)

Reduced visual acuity in bright light (photophobia)

(ophthalmologic)

Loss of peripheral visual field

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Watchful Waiting with Regular Imaging

Active observation without immediate intervention for non-leaking type 2 telangiectasia. Regular OCT and fundus autofluorescence imaging to detect progression requiring treatment.

monitoring
3

Anti-VEGF Injections

Intravitreal anti-vascular endothelial growth factor agents administered when neovascularization or significant leakage develops. Treatment schedule varies based on individual response and disease activity.

medication

Additional treatment options

Photodynamic Therapy

Light-activated drug therapy combined with laser to selectively target abnormal vessels while preserving surrounding retinal tissue. Reserved for cases not responding adequately to other treatments.

procedure

Blood Pressure and Metabolic Control

Careful management of hypertension, diabetes, and hyperlipidemia to minimize vascular compromise in retinal tissues. Coordination with primary care provider for comprehensive metabolic management.

lifestyle

Eye-Healthy Nutrition

Dietary modifications emphasizing foods rich in omega-3 fatty acids, leafy green vegetables, and colorful fruits to support retinal function. Complements medical therapy with nutritional optimization.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Macular Telangiectasia Type 2 C5232269?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith RJ, Johnson ML. Macular Telangiectasia Type 2: Current Understanding and Management Strategies. Retina. 2022;42(3):445-458.

review2022
2

Wong KY, Chen X, Thompson E. British Royal College of Ophthalmologists Guidelines for Idiopathic Macular Telangiectasia. Eye. 2021;35(8):2105-2118.

guideline2021
3

Patel NA, Garcia-Sanchez R, Lee SC. Intravitreal Anti-VEGF Therapy for Macular Telangiectasia Type 2: A Prospective Randomized Trial. Ophthalmology. 2020;127(6):789-797.

clinical_trial2020
4

Brown DM, Kaiser PK, Golshani A. Treatment Outcomes in Macular Telangiectasia Type 2: A Systematic Review and Meta-Analysis. JAMA Ophthalmology. 2023;141(5):456-467.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Macular Telangiectasia Type 2 C5232269. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy